Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

56 results about "Cellular oxygen" patented technology

Hydrogen peroxide probe as well as preparation method and application thereof

The invention relates to a hydrogen peroxide probe and a preparation method and application thereof, the hydrogen peroxide probe connects pyridinium to a difluoro boron indole electron acceptor, can induce fluorescence quenching by distorting intramolecular charge transfer, generates weak fluorescence when the concentration of hydrogen peroxide in mitochondria is low, and can detect the mitochondria. According to the present invention, the hydrogen peroxide probe is used for detecting the hydrogen peroxide concentration in the mitochondria, the continuous fluorescence response is generated when the hydrogen peroxide concentration in the mitochondria is increased, the qualitative and quantitative analysis of the hydrogen peroxide level in the mitochondria is achieved, and the hydrogen peroxide probe can target the increased lipid droplet migration after the oxidative stress is caused by the increase of the hydrogen peroxide concentration so as to well detect the oxidative stress process; the method has important significance for exploring related damage of cell oxidative stress.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Respiratory effort detection apparatus and method

Apparatus and methods are described for continuous and non-invasive detection of (1) respiratory effort, and (2) cellular oxygen requirement compared to cellular oxygen supply. The apparatus is configurable for remote patient care and configured to monitor one or more of sleep disordered breathing, hypertension, heart failure, pneumonia, asthma, chronic obstructive pulmonary disease (COPD), respiratory distress syndrome (RDS) in premature infants, and acute respiratory distress syndrome (ARDS) in children and adults. Additionally, the device is configurable to control delivery of therapy.
Owner:REVEAL BIOSENSORS INC

Nanoparticles for tumor targeted therapy and preparation method thereof

The invention discloses a nano-particle for tumor targeted therapy and a preparation method thereof.The nano-particle comprises a three-layer structure of an innermost layer ZIF-8-GOx, a middle layer Cu-PDA and an outermost layer coating lipsome-LA, the ZIF-8-GOx coated Cu-PDA coated lipsome-LA nano-particle has ultrasonic / GSH dual responsiveness, the nano-particle can specifically act on tumor cells, glucose is consumed to achieve hunger therapy, and the nano-particle has a good application prospect. Meanwhile, cell oxidative stress is intensified under the combined action with Zn ions, and high-concentration NO can be generated by virtue of ultrasonic assistance to realize ultrasonic catalytic gas treatment. Therefore, the coordination of tumor targeting ion interference treatment, hunger treatment and ultrasonic catalytic gas treatment is realized.
Owner:XINCHANG COUNTY TIANMU LAB

High-concentration aqueous H2 solution and use thereof

The invention relates to an aqueous solution comprising molecular hydrogen and at least one salt, wherein the solution has an ionic strength of 0.001 mol / l to 1 mol / l and comprises ascorbic acid or a salt thereof. The solutions are useful for improving the activation of cellular mechanisms, reducing cellular oxidative stress and cytotoxicity by transdermal administration to a subject, and for treating oxidative stress related diseases.
Owner:BLUE HYDROGEN TECHNOLOGY CO LTD

Application of DCTPP1 in inspection of abortion kit

The invention provides an application of DCTPP1 in detection of an auditing abortion kit, relates to the technical field of target spot diagnosis, and particularly provides an application of DCTPP1 as a target spot in preparation of an auditing abortion detection product, and an experimental result shows that DCTPP1 is one of key genes for auditing abortion. Specifically, after the DCTPP1 is knocked down from a human embryo trophoblast cell line HTR8 / SVneo, compared with a control group, the reduction of the DCTPP1 can cause more cell oxidation stress increase, and cell viability is reduced 24 hours later, and finally cell apoptosis occurs; in the mechanism, the DCTPP1 interacts with the RNA binding protein AUF1, and the reduction of the DCTPP1 causes the increase of oxidative stress of human embryo trophoblastic cells through the AUF1, so that apoptosis is caused. Experimental results in the application show that DCTPP1 is one of key genes for auditing abortion, and cell apoptosis can be finally caused by destroying the function of DCTPP1 in embryonic trophoblast cells through technologies such as transfection of specific siRNA and the like. In addition, the DCTPP1 knocked-down embryo trophoblast cells can be subjected to apoptosis, and the DCTPP1 knocked-down embryo trophoblast cells are one of useful genes for detecting and auditing abortion.
Owner:NANTONG UNIV

Compound functional beverage for improving tissue cell hypoxia and its preparation method and application

PendingCN123023728AVitamin b6Oxygen delivery
The application belongs to the technical field of functional drinks, and particularly relates to a compound functional beverage for improving tissue cell hypoxia and a preparation method and application thereof. 12 The compound functional beverage is prepared by using high-oxygen liquid as a base, and compounding vitamin B1, vitamin B2 and vitamin B6, wherein the high-oxygen liquid is prepared by a low-temperature oxygenation or ozone-charging process, can be absorbed through the digestive tract to realize intestinal oxygen delivery, directly improve the blood oxygen partial pressure and blood oxygen saturation of the body, and eliminate lactic acid accumulation; the water-solubility of the B-group vitamins is good, and the chemical properties are stable, so that the B-group vitamins can provide synthesis materials for coenzyme of the mitochondrial respiratory chain, and improve the oxygen uptake and utilization capacity of cells. The two can break the vicious cycle of hypoxia inducible factor-1 alpha and lactic acid, and improve the hypoxia state of tissue cells. The application can improve the blood lactic acid clearance rate of the sports population by 20% to 25%, and improve the blood oxygen saturation under the highland environment by 5% to 8%, and can also be used for hypoxia auxiliary intervention and chemotherapy sensitivity enhancement of tumor radiotherapy and chemotherapy, and is suitable for all kinds of hypoxia population.
Owner:SHAOYANG UNIV

Nanocapsule SMCPM and application thereof in preparation of medicine for treating or preventing osteosarcoma and pulmonary metastasis

The invention relates to the technical field of biological medicines, and particularly discloses a nanocapsule SMCPM and application thereof in medicines for treating or preventing osteosarcoma and pulmonary metastasis. The SMCPM is composed of a photosensitizer Ce6 carried by mesoporous silicon oxide-manganese oxide particles, an NRF2 inhibitor ML385 and an OS targeting peptide PT-7. Experiments prove that the SMCPM is high in penetrating power and strong in cell killing effect; by down-regulating NRF2 expression and reversing nuclear translocation, a biochemical inhibitory microenvironment can be effectively repaired, the tolerance of cells to active oxygen and epithelial-mesenchymal transition activated and induced by a NOTCH1 signal axis are remarkably reduced, the oxidative stress level of the cells is enhanced, and PIT-induced immunogenic cell death is promoted; the released Mn < 2 + > and double-stranded DNA can regulate and control an immunosuppressive microenvironment by activating an STING pathway in cells, thereby inhibiting the growth of osteosarcoma and preventing lung metastasis.
Owner:ZHONGNAN HOSPITAL OF WUHAN UNIV

A traditional Chinese medicine prebiotic composition for treating high-altitude hypoxia and relieving fatigue, and its preparation method.

ActiveCN118384249BAntinoxious agentsPlant ingredientsBiotechnologyHigh altitude hypoxia
This invention discloses a traditional Chinese medicine prebiotic composition for treating high-altitude hypoxia and fatigue, and its preparation method. It belongs to the field of traditional Chinese medicine technology. The prebiotic composition comprises the following raw medicinal materials in parts by weight: 2-20 parts of Polygonatum odoratum, 2-20 parts of chicory, 2-20 parts of wolfberry, 3-30 parts of Codonopsis pilosula, 4-40 parts of Astragalus membranaceus, 2-20 parts of Angelica sinensis, 2-20 parts of jujube, and 2-20 parts of turmeric. The composition of this invention can improve the body's aerobic metabolism, enhance cellular oxygen utilization, strengthen high-altitude adaptability, and improve work capacity under hypoxic conditions. Furthermore, this composition helps relieve central and musculoskeletal fatigue, while having no toxic side effects, and exhibits significant anti-fatigue, hypoxia tolerance, and immune-regulating effects.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Breathing effort sensing apparatuses and methods

Devices and methods are described for continuous and non-invasive sensing of: (1) breathing effort, and (2) cellular oxygen need vs. cellular oxygen supply. The devices configurable for remote patient care configured to monitor one or more of sleep disordered breathing, hypertension, heart failure, pneumonia, asthma, chronic obstructive pulmonary disease (COPD), respiratory distress syndrome (RDS) in premature infants, and acute respiratory distress syndrome (ARDS) in children and adults. Additionally, the devices are configurable to control delivery of therapy.
Owner:REVEAL BIOSENSORS INC

Application of SIRT3-enriched exosome in preparation of medicine for improving myocardial ischemia-reperfusion injury

The invention discloses an application of an SIRT3 enriched exosome in preparation of a medicine for improving myocardial ischemia reperfusion injury. The preparation method comprises the following steps: screening to obtain polypeptide molecular gel G12 targeting HSP60, forming recombinant protein SIRT3-G12 from the G12 and SIRT3, constructing recombinant plasmids for expressing the recombinant protein, transfecting cells for co-expression, and extracting exosomes, thereby obtaining the SIRT3-enriched exosome SIRT3-Exo. In a cell experiment, the SIRT3-Exo has the effects of improving the mitochondrial metabolism function and reducing the oxidative stress and apoptosis level of the cells on hypoxia reperfusion myocardial cells. In an animal experiment, SIRT3-Exo is injected into a myocardial ischemia area of an I / R rat, so that the cardiac function is remarkably improved, the oxidative stress and inflammatory injury level is reduced, and angiogenesis is promoted. The result shows that the SIRT3-Exo has an obvious improvement effect on the myocardial ischemia reperfusion injury.
Owner:GUANGZHOU HONGRUN BIOTECHNOLOGY CO LTD

Use of intracellular endogenous metabolites for the preparation of a medicament for the treatment and / or prevention of aging

The application discloses application of cell endogenous metabolites in preparation of medicines for treating and / or preventing aging. The cell endogenous metabolites are any one or combination of phosphocreatine, hypotaurine and / or phosphoethanolamine. The application finds that phosphocreatine, hypotaurine and phosphoethanolamine can effectively restore cell growth, reduce cell SA-beta-Gal staining intensity, improve cell mitochondrial function and increase ATP yield, restore cell mitochondrial membrane potential, alleviate damage caused by cell oxidative stress and premature aging, and also prolong the life of nematodes and restore exercise capacity in the middle of aging. Meanwhile, the three metabolites have a synergistic effect, and by adjusting the matching concentration of the three metabolites, the same cell protection effect can be achieved by mixed administration. Since the endogenous metabolites are accurate, efficient and safe, the three cell endogenous metabolites provided by the application can be used for preparing anti-aging medicines.
Owner:UNIV OF SCI & TECH OF CHINA

Yellow-rose yellow-meat boletus polysaccharide as well as preparation method and application thereof

The invention belongs to the technical field of fungal polysaccharide application, and particularly relates to a yellow-rose yellow-meat boletus polysaccharide as well as a preparation method and application thereof. The preparation method comprises the following steps: extracting crude polysaccharide from boletus rosea sporocarp through a water extraction and alcohol precipitation method, and then carrying out deproteinization, decoloration and DEAE-52 cellulose column chromatography separation and purification to obtain the purified polysaccharide BPP-1 of the boletus rosea water component. CCl4 is selected as an inducer of oxidative stress injury of the MIHA cells to construct a hepatic cell oxidative injury model, and the model is utilized to evaluate the protective effect of BPP-1 on CCl4-induced MIHA cell hepatic injury. The result shows that the BPP-1 reduces the release of ALT and AST, improves the GSH level and the SOD enzyme activity at the same time, inhibits the generation of a lipid peroxidation product MDA, and effectively reduces the damage of CCl4 to liver cells. The results show that BPP-1 has a certain protection effect on CCl4-induced hepatocyte injury, and BPP-1 may be a potential antioxidant and can alleviate oxidative injury of liver.
Owner:HAINAN NORMAL UNIV

A multi-index detection kit for assessing the effects of perifosine-mediated cellular oxidative stress toxicity and its application.

This invention discloses a multi-index detection kit for assessing the oxidative stress toxicity effects of perifosine-mediated cells and its applications, belonging to the field of biomedical technology. The multi-index kit includes a cell proliferation detection reagent, a cell apoptosis detection reagent, a fluorescent probe and corresponding buffer for reactive oxygen species detection, a lipid peroxide quantitative detection reagent, a glutathione quantitative detection reagent, a qRT-PCR reagent for detecting the expression levels of oxidation-antioxidant related genes, and a detection procedure including the order of use of the above reagents. Based on the multi-index quantitative detection and unified judgment process of cell proliferation, apoptosis, and oxidative-antioxidant homeostasis, this invention provides a reproducible and quantifiable technical solution for drug toxicity screening, drug safety evaluation, and cell biology research; it solves the problem of lack of unified standards and technical comparability in existing toxicity assessments, and is suitable for drug safety evaluation and preclinical screening.
Owner:NANTONG UNIV

Treatment of diseases and disorders associated with oxidative stress

Peptide compounds and their use in the treatment of diseases and disorders caused by or characterized by cellular oxidative stress. The disclosed compounds comprise or consist of an amino acid sequence having the formula Gly-X-Thr-Pro, where X is a sequence of 3 amino acids selected from Arg-Ala-Chs(acid). Further, the disclosed compounds comprise or consist of the amino acid sequence Gly-ArgGly-Cys(acid)-Gly-Gly-Gly-Asp-Gly.
Owner:JENIUS PHARMA LLC

Two-photon fluorescent probe and application thereof in monitoring of tumor microenvironment

The application discloses a two-photon fluorescent probe and uses the same for tumor microenvironment monitoring. The application opens the two-photon fluorescent characteristics of the material by responding to the overexpression of SO2 and H2O2 at the tumor site in stages, monitors and indicates the changes of cell oxidative stress and homeostasis balance, and is further used for early diagnosis of diseases caused by internal environment homeostasis imbalance. The application regulates the cancer cell uptake capacity of the molecule by introducing suitable lipophilic and hydrophilic groups, increases the recognition site of biological thiols by introducing conjugated olefin bonds, and further realizes the step-by-step recognition of endogenous signal molecules by using the easiness of substitution reaction, enhances the fidelity of the signal, and is expected to realize the in-situ activated two-photon fluorescence, early and accurate diagnosis of a series of diseases such as cardiovascular diseases, Alzheimer's disease and the like induced by internal environment homeostasis imbalance.
Owner:ANHUI AGRICULTURAL UNIVERSITY

Superoxide dismutase HSTM-SOD and application thereof

The invention belongs to the technical field of biological medicine, and particularly relates to superoxide dismutase HSTM-SOD and application thereof. The amino acid sequence of the superoxide dismutase HSTM-SOD provided by the invention is selected from at least one of sequences as shown in SEQ ID NO: 1 to SEQ ID NO: 8, or a sequence with more than 80% of homology with the amino acid sequence. The HSTM-SOD with different sequences, which is provided by the invention, generally has excellent thermal stability, pH stability, good compatibility and super-strong membrane crossing capability; the HSTM-SOD shows remarkable capabilities in the aspects of promoting cell sunburn repair, promoting cell oxidative damage repair, resisting ferroptosis caused by TalaA, promoting wound healing of diabetic patients, improving age-related macular degeneration and the like, and has a wide application prospect.
Owner:JINING MEDICAL UNIV

Application of pseudo-ginseng carbon quantum dots in preparation of medicine for treating renal ischemia-reperfusion injury

The invention belongs to the technical field of biological medicine, and particularly relates to application of pseudo-ginseng carbon quantum dots in preparation of a medicine for treating renal ischemia-reperfusion injury, the carbon quantum dots are synthesized by taking pseudo-ginseng as a raw material through a hydrothermal method, and the pseudo-ginseng carbon quantum dots have the antioxidant enzyme activity property, can effectively relieve cell oxidative stress and inhibit secretion of proinflammatory cytokines, and can be used for preparing a medicine for treating renal ischemia-reperfusion injury. The pseudo-ginseng carbon quantum dots specifically gather in the damaged kidney, so that the renal ischemia reperfusion injury of the mouse is obviously relieved; the pseudo-ginseng carbon quantum dots can relieve kidney injury through the following ways: reducing abundance of escherichia coli-shigella, reducing the level of indol sulfate in the kidney, regulating tryptophan-indole metabolism, regulating an AHR-Raf-ERK signal channel, down-regulating the levels of TNF-alpha and malonaldehyde, and regulating the level of glutathione. A catalytic mechanism and a multi-omics regulatory pathway of the pseudo-ginseng carbon quantum dots in renal ischemia reperfusion injury are disclosed, and experimental evidence is provided for'intestinal tract-kidney axis' in kidney disease treatment.
Owner:THE FIRST AFFILIATED HOSPITAL OF MEDICAL COLLEGE OF XIAN JIAOTONG UNIV

Antioxidant oligopeptide from tuna bone and preparation method thereof

The present application belongs to the technical field of bioengineering, and particularly relates to a tuna fish bone antioxidant oligopeptide and a preparation method thereof.The tuna fish bone antioxidant oligopeptide has good scavenging activity, and has good thermal stability and digestion resistance; the mechanism of action is to promote the release of nitric oxide (NO), improve the levels of superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), catalase (CAT) and total antioxidant capacity (T-AOC), and reduce the levels of malondialdehyde (MDA) and lactate dehydrogenase (LDH); JQYG-1 can protect HUVEC cells from oxidative damage induced by hydrogen peroxide; JQYG-1 can exert an antioxidant effect and protect vascular endothelial cells, and can provide a candidate drug for the prevention and treatment of cardiovascular and cerebrovascular diseases such as hypertension, coronary heart disease, cerebral thrombosis, myocardial infarction, atherosclerosis and heart failure.
Owner:ZHEJIANG OCEAN UNIV

Use of pig's tooth saponin in preparation of drugs for treating cerebral ischemia-reperfusion injury

The application provides application of pig's tooth saponin volatile oil in preparation of a medicine for treating cerebral ischemia-reperfusion injury, and a preparation method of the pig's tooth saponin volatile oil is as follows: pig's tooth saponin decoction pieces are taken, water and n-hexane are added, and volatile oil is obtained through steam distillation; the volatile oil is collected, anhydrous sulfuric acid is added, and water is removed; and the mixture is left overnight to obtain the pig's tooth saponin volatile oil. The prepared pig's tooth saponin volatile oil acts on key target points of VEGFA, SRC, MAPK8, PIK3CA and TNF through active ingredients of paeonol, linalool, methyl eugenol, anethole and eugenol, regulates multiple signal pathways of sphingolipids, TNF and VEGF, inhibits cell oxidative stress injury, inhibits release of inflammatory factors and regulates nerve function, so as to play a role in treating cerebral ischemia-reperfusion injury, and lay a foundation for further in-depth study on a treatment mechanism of pig's tooth saponin in treating 'opening the orifices and connecting the heart and the lung'.
Owner:GUIYANG COLLEGE OF TRADITIONAL CHINESE MEDICINE

Preparation method and application of 5-methyl kaempferol carbon quantum dots

The invention provides a preparation method of 5-methyl kaempferol carbon quantum dots. The method has the advantages that a green synthesis process is adopted, the safety is high, and the biocompatibility is good; the carbon quantum dots of the 5-methyl kaempferol prepared by the invention are used as an efficient ROS (reactive oxygen species) scavenger, have obvious antioxidant and anti-inflammatory effects, can obviously reduce oxidative injury of pulmonary epithelial cells, and can effectively promote lung injury repair of acute lung injury; compared with common kaempferol, the prepared carbon quantum dot of 5-methyl kaempferol has higher anti-inflammatory activity and better intracellular delivery efficiency, and has a better repairing effect on acute lung injury.
Owner:FUJIAN MEDICAL UNIV

Ventricular assist device integrated with lactic acid detection and flow control method thereof

The invention relates to a ventricular assist device integrated with lactic acid detection and a flow control method thereof.The ventricular assist device comprises a lactic acid sensor which comprises a signal conversion module and an electrode in direct contact with blood, and the electrode is fixed to the inner wall of a blood flow channel of the ventricular assist device; the output end of the controller generates a rotating speed adjusting instruction; and the magnetic suspension pump changes the pump rotating speed according to the rotating speed adjusting instruction. Monitoring faults between physical indexes such as blood pressure and flow and cell oxygen utilization can be solved; the problem that complication development cannot be recognized in time due to time delay in traditional lactic acid detection is solved; a doctor is helped to accurately judge the condition of a patient, accurately find the time point of using or evacuating the ventricular auxiliary equipment and optimize use parameters; doctors are helped to accurately judge patient conditions and evaluate the use effect of the ventricular assist equipment. Compared with the prior art, lactic acid detection can be carried out on a patient in the ventricular assist process, and the lactic acid change can be rapidly judged.
Owner:PANTHER TECHNOLOGY (SHENZHEN) CO LTD

Nanoparticles for tumor targeted therapy and preparation method thereof

The present invention discloses a nanoparticle for tumor targeted therapy and a preparation method thereof, wherein the nanoparticle comprises a three-layer structure of an innermost layer of ZIF-8-GOx, a middle layer of Cu-PDA, and an outermost layer of lipsome-LA, and the ZIF-8-GOx@Cu-PDA@liposome-LA nanoparticle has ultrasound / GSH dual responsiveness, and the present invention can specifically act on tumor cells, consume glucose to achieve starvation therapy, and simultaneously act with Zn ions to aggravate cell oxidative stress, and can also generate high-concentration NO with the aid of ultrasound to achieve ultrasonic catalytic gas therapy. Thus, the synergy of tumor targeted ion interference therapy, starvation therapy, and ultrasonic catalytic gas therapy is achieved.
Owner:XINCHANG COUNTY TIANMU LAB

Artificial synthesis method and application of compound theanine diglucoside TFG

The invention belongs to the technical field of chemistry, and particularly relates to an artificial synthesis method and application of a compound theanine diglucoside TFG. Theanine-fructosyl-glucose (TFG) is a Maillard reaction product, has obvious antioxidant activity, and is not systematically studied at present, so that the antioxidant activity of the theanine-fructosyl-glucose (TFG) can be obviously improved, and the antioxidant activity of the theanine-fructosyl-glucose (TFG) can be obviously improved. The invention provides an efficient artificial synthesis method of the compound TFG, the synthesis cost is reduced, a material basis is provided for subsequent research, and the method has the characteristics of economy, high efficiency, simplicity in operation, safety and the like, and is suitable for industrial production. Subsequently, activity screening of HT22 mouse hippocampal neuronal cells and HUVEC human vascular endothelial cells in vitro proves that the compound TFG can remarkably relieve cell oxidative damage induced by hydrogen peroxide (H2O2). Based on the synergistic protection effect of the TFG on neurons and vascular endothelial systems, the TFG is suitable for developing antioxidant drugs for treating Alzheimer's disease.
Owner:JILIN AGRICULTURAL UNIV

Nanoliposome with anti-cell oxidation and beta-galactosidase activity inhibition effects, preparation method and application thereof

The invention discloses a nanoliposome with anti-cell oxidation and inhibitory effects on β-galactosidase activity, a preparation method and an application thereof, which belongs to the field of medical technology and solves the problem that the anti-aging active ingredients existing in the prior art are unstable and the effect is not ideal. The nanoliposome comprises components: 8-12wt% of cycloastragenol, 8-12wt% of ceramide, 15-25wt% of lecithin, 1-5wt% of proppant, 10-20wt% of solubilizer and 10-25wt% of stabilizer. The nanoliposome with anti-cell oxidation and inhibitory effects on β-galactosidase activity provided by the invention combines the mechanism and action site of aging, compounds ceramide with cycloastragenol, significantly activates the activity of telomerase, prolongs the length of telomeres, enhances tissue repair and regeneration process, and delays aging.
Owner:WANG SHUHE BIOMEDICINE (WUHAN) CO LTD

High Concentration H2 Aqueous Solution And Its Use

The present invention concerns an aqueous solution comprising molecular hydrogen and at least one salt, wherein said solution has an ionic strength in the range from 0.001 mol / l to 1 mol / l and comprises ascorbic acid or a salt thereof. The solution can be used for ameliorating the activation of cell mechanisms that reduce cellular oxidative stress and cell toxicity by transdermal administration to a subject and for use in treating oxidative stress-related diseases.
Owner:BLUE HYDROGEN SCI SRL

Application of cell endogenous metabolite in preparation of medicine for treating and / or preventing senescence

ActiveCN119318660Areturn to normal growthImprove mitochondrial functionOrganic active ingredientsAntinoxious agentsEndogenous metabolismPremature aging
The invention discloses an application of a cell endogenous metabolite in preparation of a medicine for treating and / or preventing senescence. The cell endogenous metabolite is any one or a combination of more of phosphocreatine, hypotaurine and / or ethanolamine phosphate. The invention finds that phosphocreatine, hypotaurine and phosphoethanolamine can effectively recover cell growth, reduce SA-beta-Gal staining intensity of cells, improve mitochondrial functions of the cells, increase ATP yield, recover mitochondrial membrane potential of the cells and relieve damage and premature aging caused by oxidative stress of the cells under a specific concentration. The life of the nematodes can be prolonged; the exercise ability in the aging middle stage is recovered. Meanwhile, the three metabolites have a synergistic effect, and the same cell protection effect can be achieved by adjusting the proportioning concentration of the three metabolites and performing mixed administration. The endogenous metabolites have the characteristics of accuracy, high efficiency and safety at the same time, so that the three cell endogenous metabolites provided by the invention can be used for preparing anti-aging drugs.
Owner:UNIV OF SCI & TECH OF CHINA

Octapeptide with antioxidant activity

The invention discloses an octapeptide with antioxidant activity. The octapeptide is characterized in that the sequence of the octapeptide is amino terminal-SPDIFNPQ-carboxyl terminal. The antioxidant activity of the peptide is evaluated through the protective effect of the peptide on oxidative stress injury of HepG2 cells. Results show that the peptide can effectively relieve H2O2-induced cell oxidative stress injury, and can be further developed into a functional food additive or a medicine for relieving and treating oxidative stress related diseases.
Owner:CHONGQING UNIV

Oxygen-economized photodynamic therapy with nitric oxide-releasing photosensitizers

The subject invention relates to a novel compound and method for treating cancer in a subject using photodynamic therapy (PDT). The novel compound comprises zinc(II) phthalocyanine substituted with two or four nitric oxide (NO)-releasing moieties that release NO upon interaction with the intracellular glutathione, which reduces the cellular oxygen consumption rate, thus relieving the hypoxic status of cancer cells. Upon light irradiation, the novel compound generates reactive oxygen species (ROS), induces cytotoxicity under a hypoxic condition, overcoming the oxygen-dependent nature of PDT, and elicits the release of damage-associated molecular patterns, inducing the maturation of dendritic cells and triggering an antitumor immune response.
Owner:CITY UNIVERSITY OF HONG KONG